Michael K Freeman
Overview
Explore the profile of Michael K Freeman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
19113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bui A, Lavado R, Johnson E, Brooks B, Freeman M, Graves C, et al.
Bull World Health Organ
. 2015 Oct;
93(8):566-576D.
PMID: 26478614
Objective: To collect, compile and evaluate publicly available national health accounts (NHA) reports produced worldwide between 1996 and 2010. Methods: We downloaded country-generated NHA reports from the World Health Organization...
2.
Murray C, Lozano R, Flaxman A, Serina P, Phillips D, Stewart A, et al.
BMC Med
. 2014 Jan;
12:5.
PMID: 24405531
Background: Monitoring progress with disease and injury reduction in many populations will require widespread use of verbal autopsy (VA). Multiple methods have been developed for assigning cause of death from...
3.
Ng M, Freeman M, Fleming T, Robinson M, Dwyer-Lindgren L, Thomson B, et al.
JAMA
. 2014 Jan;
311(2):183-92.
PMID: 24399557
Importance: Tobacco is a leading global disease risk factor. Understanding national trends in prevalence and consumption is critical for prioritizing action and evaluating tobacco control progress. Objective: To estimate the...
4.
Murray C, Dellavalle R, Danaei G, Fahimi A, Flaxman D, Gabriel S, et al.
JAMA
. 2013 Jul;
310(6):591-608.
PMID: 23842577
Importance: Understanding the major health problems in the United States and how they are changing over time is critical for informing national health policy. Objectives: To measure the burden of...
5.
Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H, et al.
Lancet
. 2012 Dec;
380(9859):2224-60.
PMID: 23245609
Background: Quantification of the disease burden caused by different risks informs prevention by providing an account of health loss different to that provided by a disease-by-disease analysis. No complete revision...
6.
Murray C, Vos T, Lozano R, Naghavi M, Flaxman A, Michaud C, et al.
Lancet
. 2012 Dec;
380(9859):2197-223.
PMID: 23245608
Background: Measuring disease and injury burden in populations requires a composite metric that captures both premature mortality and the prevalence and severity of ill-health. The 1990 Global Burden of Disease...
7.
Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M, et al.
Lancet
. 2012 Dec;
380(9859):2163-96.
PMID: 23245607
Background: Non-fatal health outcomes from diseases and injuries are a crucial consideration in the promotion and monitoring of individual and population health. The Global Burden of Disease (GBD) studies done...
8.
Salomon J, Wang H, Freeman M, Vos T, Flaxman A, Lopez A, et al.
Lancet
. 2012 Dec;
380(9859):2144-62.
PMID: 23245606
Background: Healthy life expectancy (HALE) summarises mortality and non-fatal outcomes in a single measure of average population health. It has been used to compare health between countries, or to measure...
9.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al.
Lancet
. 2012 Dec;
380(9859):2095-128.
PMID: 23245604
Background: Reliable and timely information on the leading causes of death in populations, and how these are changing, is a crucial input into health policy debates. In the Global Burden...
10.
Lozano R, Freeman M, James S, Campbell B, Lopez A, Flaxman A, et al.
Popul Health Metr
. 2011 Aug;
9:50.
PMID: 21819580
Background: InterVA is a widely disseminated tool for cause of death attribution using information from verbal autopsies. Several studies have attempted to validate the concordance and accuracy of the tool,...